
- Pharmaceutical Technology, February 2022 Issue
- Volume 46
- Issue 2
- Pages: 12
Rapid Mass Photometer
The SamuxMP enables routine quantification of empty/full AAV capsid ratios
Designed to be easy to use with only basic training, the SamuxMP
mass photometer is utilized in adeno-associated virus (AAV)
analytics. The instrument has a mass range tailored for AAV analysis and
provides accurate results in less than five minutes from sample loading to final result. Combined with low-operational costs and a small footprint, the SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization.
The SamuxMP is designed to overcome the drawbacks of the current analytical methods by enabling users to rapidly and cost- effectively determine empty/full capsid ratios for AAVs of any serotype at the bench using low sample volumes and concentrations with minimal sample preparation. This is intended to enhance productivity and speed up workflows through more frequent analyses in-house, making R&D and process development of gene therapies and AAV-based therapeutics significantly more efficient.
Articles in this issue
over 3 years ago
Analysis of mRNA Therapeutics and Vaccinesover 3 years ago
What’s Next for COVID-19 Vaccines and Variants?over 3 years ago
Synthesis, Extraction, and Purification of Cannabinoidsover 3 years ago
Accelerating Workforce Training on Single-Use Technologiesover 3 years ago
How to Effectively Implement Pharma 4.0 Technologiesover 3 years ago
Serialization and Aggregation from a Manufacturing Perspectiveover 3 years ago
Driving Consistency in Validation Managementover 3 years ago
What’s in Your Quality Manual?Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




